Ryanodex 250 MG vials
Ended Awarded
- Contract number
- SPE2D325F327N
- Awardee
-
Eagle Pharmaceuticals, Inc. UEI VRQKPMHD3CK7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,585
Award facts
- Contract value 100% obligated
- $10,585.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Westwood, NJ 07677, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order contract valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250 mg vials. The contract, awarded on August 18, 2025, with an ultimate completion date of August 21, 2025, was issued without set-aside designation under firm fixed-price terms. Performance will take place in Westwood, New Jersey. This delivery order is issued under Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, valued at $30.9 million and effective through January 2029, which enables efficient federal procurement of pharmaceutical and drug-related products across the VA and Defense Logistics Agency.
Eagle Pharmaceuticals, a pharmaceutical manufacturer headquartered in Woodcliff Lake, New Jersey, specializes in producing Ryanodex, a critical injectable medication used to treat and prevent malignant hyperthermia. The company has established itself as a primary supplier to federal medical agencies, with a consistent track record of delivering specialized pharmaceutical products to the Department of Defense and Department of Veterans Affairs through open market competition. This delivery order represents a continuation of Eagle Pharmaceuticals' role in supporting federal medical readiness by supplying essential injectable medications through the established FSS contract vehicle.
Quick answers
Who was awarded contract SPE2D325F327N?
SPE2D325F327N was awarded to Eagle Pharmaceuticals, Inc. by Medical Supply Chain (Troop Support) on August 18, 2025.
How much is contract SPE2D325F327N worth?
The government has obligated $10,585 on SPE2D325F327N.
Is contract SPE2D325F327N an order under another contract?
Yes. SPE2D325F327N is a delivery order under SPE2D018D0006, an indefinite delivery contract.
Was contract SPE2D325F327N competed?
The extent of competition for SPE2D325F327N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award